HFS
TEVA icon

HL Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

HL Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-35,840
Closed -$631K – 692
2017
Q3 		$631K Buy
35,840
+14,601
+69% +$329K 0.01% 439
2017
Q2 		$706K Buy
21,239
+5,516
+35% +$171K 0.01% 403
2017
Q1 		$505K Sell
15,723
-17
-0.1% -$580 0.01% 453
2016
Q4 		$571K Buy
15,740
+9,601
+156% +$383K 0.01% 415
2016
Q3 		$282K Sell
6,139
-1,999
-25% -$104K 0.01% 547
2016
Q2 		$409K Sell
8,138
-518
-6% -$27.6K 0.01% 474
2016
Q1 		$463K Buy
8,656
+33
+0.4% +$1.94K 0.01% 447
2015
Q4 		$566K Buy
8,623
+1,540
+22% +$95.2K 0.01% 417
2015
Q3 		$400K Buy
7,083
+250
+4% +$16.2K 0.01% 470
2015
Q2 		$404K Sell
6,833
-172
-2% -$10.6K 0.01% 497
2015
Q1 		$436K Sell
7,005
-971
-12% -$56.5K 0.01% 492
2014
Q4 		$459K Buy
7,976
+773
+11% +$43.1K 0.01% 458
2014
Q3 		$387K Buy
7,203
+3
+0% +$159 0.01% 468
2014
Q2 		$377K Sell
7,200
-9,390
-57% -$480K 0.01% 487
2014
Q1 		$877K Sell
16,590
-22,232
-57% -$1.03M 0.03% 284
2013
Q4 		$1.56M Sell
38,822
-65,876
-63% -$2.59M 0.05% 206
2013
Q3 		$3.96M Sell
104,698
-1,173
-1% -$45.8K 0.14% 96
2013
Q2 		$4.15M Buy
+105,871
New +$4.12M 0.15% 89

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

HL Financial Services's TEVA Position: Q4 2017 in Review

HL Financial Services sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 35,840 shares — an estimated $631K sold.

HL Financial Services first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $4.15M in Q2 2013. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • HL Financial Services reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • HL Financial Services sold 35,840 Teva Pharmaceuticals shares in Q4 2017, an estimated $631K.
  • HL Financial Services first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • HL Financial Services's Teva Pharmaceuticals position peaked at $4.15M in Q2 2013.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on HL Financial Services's 13F filing for Q4 2017, filed 1 Feb 2018.